title: Rebound of disease activity during pregnancy after withdrawal of fingolimod.
authors.forename: A P
authors.initials: AP
authors.lastname: Sempere
authors.forename: L
authors.initials: L
authors.lastname: Berenguer-Ruiz
authors.forename: E
authors.initials: E
authors.lastname: Feliu-Rey
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004185:Disability Evaluation; D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications* / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*; D011409:Propylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D008775:Methylprednisolone
keywords: fingolimod; multiple sclerosis; pregnancy; therapy